"Lung Neoplasms" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Tumors or cancer of the LUNG.
| Descriptor ID |
D008175
|
| MeSH Number(s) |
C04.588.894.797.520 C08.381.540 C08.785.520
|
| Concept/Terms |
Lung Neoplasms- Lung Neoplasms
- Pulmonary Neoplasms
- Neoplasms, Lung
- Lung Neoplasm
- Neoplasm, Lung
- Neoplasms, Pulmonary
- Neoplasm, Pulmonary
- Pulmonary Neoplasm
Lung Cancer- Lung Cancer
- Cancer, Lung
- Cancers, Lung
- Lung Cancers
- Pulmonary Cancer
- Cancer, Pulmonary
- Cancers, Pulmonary
- Pulmonary Cancers
- Cancer of the Lung
- Cancer of Lung
|
Below are MeSH descriptors whose meaning is more general than "Lung Neoplasms".
Below are MeSH descriptors whose meaning is more specific than "Lung Neoplasms".
This graph shows the total number of publications written about "Lung Neoplasms" by people in this website by year, and whether "Lung Neoplasms" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1995 | 1 | 0 | 1 |
| 1996 | 0 | 1 | 1 |
| 1997 | 4 | 0 | 4 |
| 1999 | 3 | 2 | 5 |
| 2000 | 1 | 0 | 1 |
| 2001 | 0 | 1 | 1 |
| 2002 | 6 | 0 | 6 |
| 2003 | 2 | 1 | 3 |
| 2004 | 7 | 4 | 11 |
| 2005 | 4 | 1 | 5 |
| 2006 | 5 | 1 | 6 |
| 2007 | 4 | 0 | 4 |
| 2008 | 6 | 2 | 8 |
| 2009 | 6 | 1 | 7 |
| 2010 | 5 | 2 | 7 |
| 2011 | 6 | 3 | 9 |
| 2012 | 6 | 0 | 6 |
| 2013 | 8 | 1 | 9 |
| 2014 | 8 | 1 | 9 |
| 2015 | 14 | 1 | 15 |
| 2016 | 16 | 1 | 17 |
| 2017 | 17 | 3 | 20 |
| 2018 | 9 | 3 | 12 |
| 2019 | 10 | 1 | 11 |
| 2020 | 15 | 0 | 15 |
| 2021 | 18 | 2 | 20 |
| 2022 | 10 | 1 | 11 |
| 2023 | 12 | 0 | 12 |
To return to the timeline,
click here.
Below are the most recent publications written about "Lung Neoplasms" by people in Profiles.
-
Immune checkpoint inhibition and single fraction stereotactic radiosurgery in brain metastases from non-small cell lung cancer: an international multicenter study of 395 patients. J Neurooncol. 2023 Oct; 165(1):63-77.
-
Increased interleukin-6/C-reactive protein levels are associated with the upregulation of the adenosine pathway and serve as potential markers of therapeutic resistance to immune checkpoint inhibitor-based therapies in non-small cell lung cancer. J Immunother Cancer. 2023 10; 11(10).
-
The Interplay Between Radiation Dose, Volume, and Systemic Therapy. Int J Radiat Oncol Biol Phys. 2023 Aug 01; 116(5):967-971.
-
Smoking, blood DNA methylation sites and lung cancer risk. Environ Pollut. 2023 Oct 01; 334:122153.
-
Prevalence and Correlates of Cardiovascular, Pulmonary, Cancer, and Mental Health Comorbidities Among Adults With HIV Who Smoke. J Assoc Nurses AIDS Care. 2023 Jul-Aug 01; 34(4):363-375.
-
PZR promotes tumorigenicity of lung cancer cells by regulating cell migration and invasion via modulating oxidative stress and cell adhesion. Aging (Albany NY). 2023 06 06; 15(11):4949-4962.
-
Analysis of Geographic Accessibility of Breast, Lung, and Colorectal Cancer Screening Centers Among American Indian and Alaskan Native Tribes. J Am Coll Radiol. 2023 07; 20(7):642-651.
-
Chitosan functionalized PCL nanoparticles bearing tyrosine kinase inhibitor osimertinib mesylate for effective lung cancer therapy. Pharm Dev Technol. 2023 Jun; 28(5):460-478.
-
Progress and challenges in RET-targeted cancer therapy. Front Med. 2023 Apr; 17(2):207-219.
-
The heterogeneous transition state of resistance to RET kinase inhibitors converges on ERK1/2-driven Aurora A/B kinases. Drug Resist Updat. 2023 05; 68:100958.